ZA772612B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number: ZA772612B
Authority: ZA; South Africa
Prior art keywords: pharmaceutical compositions; pharmaceutical; compositions
Prior art date: 1976-05-14

Application number

ZA00772612A

Other languages

English (en)

Inventor

G Durant

M Vickers

C Ganellin

Original Assignee

Smith Kline French Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1976-05-14

Filing date

1977-05-02

Publication date

1978-04-26

1977-05-02 Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab

1978-04-26 Publication of ZA772612B publication Critical patent/ZA772612B/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/30—Isothioureas
- C07C335/32—Isothioureas having sulfur atoms of isothiourea groups bound to acyclic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/42—Sulfur atoms

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Transplantation (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

ZA00772612A 1976-05-14 1977-05-02 Pharmaceutical compositions ZA772612B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB19994/76A GB1592453A (en)	1976-05-14	1976-05-14	Aminoalkyl esters of carbarimidothioic acid and compositions having immunosuppressant activity

Publications (1)

Publication Number	Publication Date
ZA772612B true ZA772612B (en)	1978-04-26

Family

ID=10138568

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA00772612A ZA772612B (en)	1976-05-14	1977-05-02	Pharmaceutical compositions

Country Status (23)

Country	Link
US (1)	US4294854A (xx)
JP (1)	JPS532420A (xx)
AR (1)	AR218872A1 (xx)
AT (1)	AT359521B (xx)
AU (1)	AU509573B2 (xx)
BE (1)	BE854553A (xx)
CA (1)	CA1086758A (xx)
CH (1)	CH620203A5 (xx)
DE (1)	DE2721830A1 (xx)
DK (1)	DK211277A (xx)
ES (1)	ES458756A1 (xx)
FI (1)	FI771400A (xx)
FR (2)	FR2351098A1 (xx)
GB (1)	GB1592453A (xx)
HU (1)	HU174978B (xx)
IE (1)	IE45144B1 (xx)
IL (1)	IL52011A (xx)
LU (1)	LU77332A1 (xx)
NL (1)	NL7705331A (xx)
NO (1)	NO771697L (xx)
PT (1)	PT66509B (xx)
SE (1)	SE7705658L (xx)
ZA (1)	ZA772612B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0672244B2 (ja) *	1984-12-12	1994-09-14	三菱マテリアル株式会社	貴金属造粒装置
WO1994028897A2 (en) *	1993-06-07	1994-12-22	The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services	Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection
AU3230895A (en) *	1994-08-18	1996-03-14	Chugai Seiyaku Kabushiki Kaisha	Amino acid derivative having nitrogen monoxide synthetase inhibitor activity
US7645873B2 (en) *	2003-03-20	2010-01-12	The Scripps Research Institute	6″-amino-6″-deoxygalactosylceramides
EP2058011A1 (en) *	2007-11-07	2009-05-13	Wittycell	Nkt cell activating gycolipids covalently bound antigens and/or drug
CN102215864A (zh) *	2008-10-08	2011-10-12	威蒂赛尔公司	用于抗流感的疫苗组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2648710A (en) *	1950-09-22	1953-08-11	Hoffmann La Roche	Bis-quaternary salts of 1:10-bis-(dialkylamino)-5:6-dithia-decane
US2813102A (en) *	1956-04-10	1957-11-12	American Home Prod	2-(di-lower alkylaminoethylmercapto)-imidazolines and their acid addition salts and preparation thereof
US4152453A (en) *	1975-12-01	1979-05-01	Smith Kline & French Laboratories Limited	Pharmacologically active compounds and compositions and methods of use

1976
- 1976-05-14 GB GB19994/76A patent/GB1592453A/en not_active Expired
1977
- 1977-05-02 ZA ZA00772612A patent/ZA772612B/xx unknown
- 1977-05-03 FI FI771400A patent/FI771400A/fi not_active Application Discontinuation
- 1977-05-04 AT AT318277A patent/AT359521B/de not_active IP Right Cessation
- 1977-05-04 IL IL52011A patent/IL52011A/xx unknown
- 1977-05-04 PT PT66509A patent/PT66509B/pt unknown
- 1977-05-10 IE IE947/77A patent/IE45144B1/en unknown
- 1977-05-11 AU AU25079/77A patent/AU509573B2/en not_active Expired
- 1977-05-11 JP JP5483077A patent/JPS532420A/ja active Pending
- 1977-05-11 CH CH589877A patent/CH620203A5/fr not_active IP Right Cessation
- 1977-05-12 BE BE177510A patent/BE854553A/xx not_active IP Right Cessation
- 1977-05-13 ES ES458756A patent/ES458756A1/es not_active Expired
- 1977-05-13 NL NL7705331A patent/NL7705331A/xx not_active Application Discontinuation
- 1977-05-13 AR AR267623A patent/AR218872A1/es active
- 1977-05-13 DK DK211277A patent/DK211277A/da not_active Application Discontinuation
- 1977-05-13 DE DE19772721830 patent/DE2721830A1/de not_active Withdrawn
- 1977-05-13 HU HU77SI1576A patent/HU174978B/hu unknown
- 1977-05-13 NO NO771697A patent/NO771697L/no unknown
- 1977-05-13 LU LU77332A patent/LU77332A1/xx unknown
- 1977-05-13 FR FR7714766A patent/FR2351098A1/fr active Granted
- 1977-05-13 CA CA278,412A patent/CA1086758A/en not_active Expired
- 1977-05-16 SE SE7705658A patent/SE7705658L/xx unknown
1979
- 1979-10-09 US US06/082,836 patent/US4294854A/en not_active Expired - Lifetime
1980
- 1980-11-17 FR FR8024334A patent/FR2472935A1/fr not_active Withdrawn

Also Published As

Publication number	Publication date
DK211277A (da)	1977-11-15
JPS532420A (en)	1978-01-11
IL52011A (en)	1982-05-31
CH620203A5 (xx)	1980-11-14
AU509573B2 (en)	1980-05-15
FR2351098B1 (xx)	1982-06-18
IE45144L (en)	1977-11-14
CA1086758A (en)	1980-09-30
NO771697L (no)	1977-11-15
HU174978B (hu)	1980-04-28
LU77332A1 (xx)	1977-08-29
DE2721830A1 (de)	1977-11-24
ATA318277A (de)	1980-04-15
SE7705658L (sv)	1977-11-15
AU2507977A (en)	1978-11-16
ES458756A1 (es)	1978-03-01
IE45144B1 (en)	1982-06-30
FR2472935A1 (fr)	1981-07-10
GB1592453A (en)	1981-07-08
BE854553A (fr)	1977-11-14
FI771400A (xx)	1977-11-15
AT359521B (de)	1980-11-10
US4294854A (en)	1981-10-13
AR218872A1 (es)	1980-07-15
FR2351098A1 (fr)	1977-12-09
NL7705331A (nl)	1977-11-16
PT66509A (en)	1977-06-01
PT66509B (en)	1978-10-16

Publication	Publication Date	Title
ZA771091B (en)	1978-01-25	Pharmaceutical compositions
ZA774920B (en)	1979-03-28	Pharmaceutical compositions
PT66622B (en)	1978-11-07	Pharmaceutical compositions
JPS52113976A (en)	1977-09-24	Pharmaceutical composition
JPS5362838A (en)	1978-06-05	Pharmaceutical composition
AU3111677A (en)	1979-06-07	Pharmaceutical compositions
ZA771003B (en)	1978-03-29	Pharmaceutical compositions containing pyrethrinoides
NZ183551A (en)	1978-09-20	Aminochromanols and pharmaceutical compositions containingthem
AU3152677A (en)	1979-06-21	Pharmaceutical composition
NZ184539A (en)	1980-03-05	2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine pharmaceutical compositions
NZ186147A (en)	1979-10-25	Sterolin pharmaceutical compositions
AU2609277A (en)	1978-12-21	Pharmaceutical compositions
AU2649977A (en)	1979-01-04	Pharmaceutical composition
JPS5356634A (en)	1978-05-23	Pharmaceutical composition
NZ183549A (en)	1978-11-13	Amidinopencillanoyloxy-alkyl-amoxycillinates and pharmaceutical compositions
IL52103A0 (en)	1977-07-31	Pharmaceutical compositions containing naphthopyrane derivvatives
ZA772612B (en)	1978-04-26	Pharmaceutical compositions
AU2574877A (en)	1978-12-07	Pharmaceutical compositions
GB1547206A (en)	1979-06-06	Pharmaceutical compositions
HK3984A (en)	1984-01-20	Pharmaceutical compositions
NZ183756A (en)	1978-12-18	Bis-penicillanoyloxy-alkanes and pharmaceutical compositions
JPS5283918A (en)	1977-07-13	Pharmaceutical composition
NZ183436A (en)	1979-07-11	Substituted phenylguanidines and pharmaceutical compositions
ZA771408B (en)	1978-04-26	Pharmaceutical compositions
JPS52122633A (en)	1977-10-15	Pharmaceutical composition